Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease

NCT02982850 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Valve Heart Disease

Interventions

DRUG: Dabigatran
DRUG: Acetylsalicylic acid
DRUG: Warfarin

Sponsor

Asan Medical Center

Collaborators

[object Object]